Non-Linear Models in Metastatic Cancer Analysis
- 1 Department of Nursing and Allied Health, Norfolk State University, Norfolk, USA
Abstract
Metastatic cancer progression is governed by complex, nonlinear biological processes, including inter-site tumor interactions, resource limitations, and heterogeneous responses to therapy. While linear models may provide reasonable approximations in early-stage or localized disease, they are generally inadequate for capturing the dynamics of metastatic spread. In this study, we propose a nonlinear state-space modeling framework to describe the evolution of latent tumor burden across multiple anatomical sites. The model incorporates nonlinear growth dynamics, metastatic seeding, and treatment effects, and relates unobserved states to clinical measurements through nonlinear observation functions. To infer the latent states from noisy and partial observations, we employ advanced sequential estimation techniques, including the Extended Kalman Filter, Unscented Kalman Filter, and Particle Filtering methods. The performance of the proposed approach is evaluated through simulation studies designed to reflect clinically relevant metastatic scenarios. Results demonstrate that nonlinear models significantly improve estimation accuracy and better capture key features of metastatic progression, such as saturation effects and treatment resistance, compared to linear approximations. These findings underscore the importance of nonlinear modeling frameworks in enhancing predictive accuracy and supporting decision-making in precision oncology.
- Sung, H., Ferlay, J., Siegel, R.L., Laversanne, M., Soerjomataram, I., Jemal, A., et al . (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians , 71, 209-249. https://doi.org/10.3322/caac.21660
- Foreman, K.J., Marquez, N., Dolgert, A., Fukutaki, K., Fullman, N., McGaughey, M., et al . (2018) Forecasting Life Expectancy, Years of Life Lost, and All-Cause and Cause-Specific Mortality for 250 Causes of Death: Reference and Alternative Scenarios for 2016-40 for 195 Countries and Territories. The Lancet , 392, 2052-2090. https://doi.org/10.1016/s0140-6736(18)31694-5
- Raychaudhuri, R., Lin, D.W. and Montgomery, R.B. (2025) Prostate Cancer. JAMA , 333, 1433. https://doi.org/10.1001/jama.2025.0228
- Martin, R.M., Turner, E.L., Young, G.J., Metcalfe, C., Walsh, E.I., Lane, J.A., et al . (2024) Prostate-specific Antigen Screening and 15-Year Prostate Cancer Mortality. JAMA , 331, 1460. https://doi.org/10.1001/jama.2024.4011
- Gupta, N., Sudhakar, D.V.S., Gangwar, P.K., Sankhwar, S.N., Gupta, N.J., Chakraborty, B., et al . (2017) Mutations in the Prostate Specific Antigen (PSA/KLK3) Correlate with Male Infertility. Scientific Reports , 7, Article No. 11225. https://doi.org/10.1038/s41598-017-10866-1
- Boeri, L., Capogrosso, P., Cazzaniga, W., Ventimiglia, E., Pozzi, E., Belladelli, F., et al . (2021) Infertile Men Have Higher Prostate-Specific Antigen Values than Fertile Individuals of Comparable Age. European Urology , 79, 234-240. https://doi.org/10.1016/j.eururo.2020.08.001
- Warner, E., Herberts, C., Fu, S., Yip, S., Wong, A., Wang, G., et al . (2021) BRCA2 , ATM , and CDK12 Defects Differentially Shape Prostate Tumor Driver Genomics and Clinical Aggression. Clinical Cancer Research , 27, 1650-1662. https://doi.org/10.1158/1078-0432.ccr-20-3708
- Tewari, A.K., Stockert, J.A., Yadav, S.S., Yadav, K.K. and Khan, I. (2018) Inflammation and Prostate Cancer. In: Advances in Experimental Medicine and Biology , Springer International Publishing, 41-65. https://doi.org/10.1007/978-3-319-95693-0_3
- Jensen, T.K., Andersson, A., Jørgensen, N., Andersen, A., Carlsen, E., Petersen, J.H., et al . (2004) Body Mass Index in Relation to Semen Quality and Reproductive Hormonesamong 1,558 Danish Men. Fertility and Sterility , 82, 863-870. https://doi.org/10.1016/j.fertnstert.2004.03.056
- de Melo, P. and Rose, M. (2026) A Stochastic Framework for Evaluation of Prostate Cancer Progression and Treatment Dynamics. Cancer Research Journal , 14, 17-29. https://doi.org/10.11648/j.crj.20261402.11